Credit Suisse’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $972K | Buy |
51,918
+508
| +1% | +$10.2K | ﹤0.01% | 2286 |
|
|
2023
Q4 | $1.16M | Sell |
51,410
-3,432
| -6% | -$74.4K | ﹤0.01% | 2241 |
|
|
2023
Q3 | $1.36M | Sell |
54,842
-1,646
| -3% | -$41.4K | ﹤0.01% | 2082 |
|
|
2023
Q2 | $1.59M | Buy |
56,488
+8,740
| +18% | +$217K | ﹤0.01% | 2083 |
|
|
2023
Q1 | $1.07M | Buy |
47,748
+2,925
| +7% | +$76.6K | ﹤0.01% | 2290 |
|
|
2022
Q4 | $1.19M | Buy |
44,823
+12,222
| +37% | +$399K | ﹤0.01% | 2227 |
|
|
2022
Q3 | $926K | Buy |
32,601
+4,493
| +16% | +$116K | ﹤0.01% | 2384 |
|
|
2022
Q2 | $586K | Buy |
28,108
+1,366
| +5% | +$25.6K | ﹤0.01% | 2743 |
|
|
2022
Q1 | $580K | Buy |
26,742
+1,279
| +5% | +$27.8K | ﹤0.01% | 2891 |
|
|
2021
Q4 | $707K | Buy |
+25,463
| New | +$617K | ﹤0.01% | 3579 |
|
|
2021
Q1 | – | Sell |
-15,060
| Closed | -$133K | – | 4315 |
|
|
2020
Q4 | $133K | Buy |
+15,060
| New | +$123K | ﹤0.01% | 4152 |
|
|
2020
Q2 | – | Sell |
-32,512
| Closed | -$219K | – | 3970 |
|
|
2020
Q1 | $219K | Buy |
32,512
+8,709
| +37% | +$82.5K | ﹤0.01% | 3599 |
|
|
2019
Q4 | $277K | Sell |
23,803
-6,314
| -21% | -$71.3K | ﹤0.01% | 3850 |
|
|
2019
Q3 | $311K | Buy |
30,117
+6,774
| +29% | +$66.6K | ﹤0.01% | 3676 |
|
|
2019
Q2 | $219K | Sell |
23,343
-7,950
| -25% | -$61.2K | ﹤0.01% | 3816 |
|
|
2019
Q1 | $221K | Buy |
31,293
+1,015
| +3% | +$8.7K | ﹤0.01% | 3731 |
|
|
2018
Q4 | $223K | Buy |
30,278
+511
| +2% | +$4.28K | ﹤0.01% | 3633 |
|
|
2018
Q3 | $260K | Sell |
29,767
-10,891
| -27% | -$111K | ﹤0.01% | 3579 |
|
|
2018
Q2 | $458K | Buy |
40,658
+2,173
| +6% | +$25.9K | ﹤0.01% | 3468 |
|
|
2018
Q1 | $428K | Buy |
38,485
+1,466
| +4% | +$18.4K | ﹤0.01% | 3432 |
|
|
2017
Q4 | $473K | Sell |
37,019
-14,845
| -29% | -$196K | ﹤0.01% | 3460 |
|
|
2017
Q3 | $738K | Buy |
51,864
+25,473
| +97% | +$319K | ﹤0.01% | 3297 |
|
|
2017
Q2 | $340K | Sell |
26,391
-6,061
| -19% | -$78.1K | ﹤0.01% | 3388 |
|
|
2017
Q1 | $466K | Sell |
32,452
-10,319
| -24% | -$152K | ﹤0.01% | 3333 |
|
|
2016
Q4 | $668K | Buy |
42,771
+15,851
| +59% | +$217K | ﹤0.01% | 3292 |
|
|
2016
Q3 | $317K | Sell |
26,920
-708
| -3% | -$9.32K | ﹤0.01% | 3634 |
|
|
2016
Q2 | $384K | Sell |
27,628
-8,570
| -24% | -$114K | ﹤0.01% | 3567 |
|
|
2016
Q1 | $421K | Sell |
36,198
-556
| -2% | -$7.07K | ﹤0.01% | 3343 |
|
|
2015
Q4 | $603K | Buy |
36,754
+23,030
| +168% | +$366K | ﹤0.01% | 3222 |
|
|
2015
Q3 | $187K | Sell |
13,724
-12,110
| -47% | -$164K | ﹤0.01% | 3946 |
|
|
2015
Q2 | $327K | Sell |
25,834
-1,005
| -4% | -$11.4K | ﹤0.01% | 3979 |
|
|
2015
Q1 | $318K | Buy |
26,839
+9,047
| +51% | +$104K | ﹤0.01% | 3829 |
|
|
2014
Q4 | $222K | Buy |
17,792
+6,329
| +55% | +$64.6K | ﹤0.01% | 4220 |
|
|
2014
Q3 | $106K | Sell |
11,463
-12,008
| -51% | -$92.1K | ﹤0.01% | 4287 |
|
|
2014
Q2 | $153K | Sell |
23,471
-81,104
| -78% | -$536K | ﹤0.01% | 4450 |
|
|
2014
Q1 | $844K | Buy |
104,575
+24,070
| +30% | +$237K | ﹤0.01% | 3268 |
|
|
2013
Q4 | $803K | Buy |
80,505
+58,851
| +272% | +$408K | ﹤0.01% | 3456 |
|
|
2013
Q3 | $131K | Buy |
21,654
+6,635
| +44% | +$38K | ﹤0.01% | 4067 |
|
|
2013
Q2 | $77K | Buy |
+15,019
| New | +$77K | ﹤0.01% | 4062 |
|
Other funds holding CCRN
WA
SFM
ACB
RA
Credit Suisse's CCRN Position: Q1 2024 in Review
Credit Suisse increased its Cross Country Healthcare (CCRN) stake by 0.99% in Q1 2024, buying an estimated $10.2K and bringing the position to 51,918 shares worth $972K. The position accounts for ﹤0.01% of the portfolio, ranked #2286.
Credit Suisse first reported a position in CCRN in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.59M in Q2 2023. 175 funds tracked by Wall St. Rank hold CCRN as of Q1 2024.
- Credit Suisse held 51,918 shares of Cross Country Healthcare worth $972K as of Q1 2024.
- Credit Suisse bought 508 Cross Country Healthcare shares in Q1 2024, an estimated $10.2K.
- Cross Country Healthcare made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2286 holding.
- Credit Suisse first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 39 quarters since.
- Credit Suisse's Cross Country Healthcare position peaked at $1.59M in Q2 2023.
- 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.